BostonGene
Presence
Executives
View the org chart displaying its 6 main executives
Most searched biographies at BostonGene
- Andrew Feinberg, President and Chief Executive Officer
- Ned Segal, Board Member
- Melissa Olsson, Vice President, Finance
Popular executive movements at BostonGene
- Ned Segal has joined the company as Board Member (posted on February 23 2024).
- Joe Lennerz has joined the company as Chief Scientific Officer (posted on February 23 2024).
- Mark Hiatt has joined the company as Senior Vice President of Market Access and Strategy (posted on February 23 2024).
Create your alert
to follow the executive moves at BostonGene.
Biotechnology
BostonGene has 2,297 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Johnson & Johnson has announced the acquisition of Proteologix (posted on May 20 2024).
- Rapport Therapeutics has just announced a $100 Million fundraising (posted on May 20 2024).
- Lycia Therapeutics has just announced a $107 Million fundraising (posted on May 15 2024).
Popular contacts in Biotechnology
News
Press releases by BostonGene
- BostonGene and Saga University Announce Collaboration to Uncover Biomarkers for Improved Immunotherapy Response in Lung Cancer Patients | BostonGene
- BostonGene Announces Acceptance of Eight Abstracts to be Presented at the American Association for Cancer Research Annual Meeting 2024 | BostonGene
- Comparative analysis of a predictive transcriptomic model and functional gene expression signatures (FGES) for tertiary lymphoid structure (TLS) detection in lung adenocarcinoma (LUAD) | BostonGene
- BostonGene Recognized as Designated Laboratory for the ComboMATCH Precision Medicine Clinical Trial | BostonGene
- BostonGene Announces Publication in Collaboration with National Cancer Institute and National Institute of Allergy and Infectious Diseases in Cancer Cell - Bostongene
- Transgene, NEC, and BostonGene Expand Collaboration for Phase I/II Clinical Trial of Neoantigen Cancer Vaccine TG4050 - Bostongene
- BostonGene Wins Four GlobalData’s Clinical Trials Arena Excellence Awards - Bostongene
- News - Bostongene
- Frost & Sullivan Recognizes BostonGene with Frost & Sullivan’s Enabling Technology Leadership Award for Revolutionizing Precision Oncology Diagnostics - Bostongene
- BostonGene Bolsters Leadership Team to Accelerate Innovation and Growth - Bostongene
- View more press releases Close
Social media about BostonGene
- BostonGene on Wikipedia, Google News & Yahoo Finance
- BostonGene on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Andrew Feinberg 
